The role of SBRT as an ablative treatment in oligometastatic patients
| dc.contributor.author | Debén Méndez, Beatriz | |
| dc.contributor.author | Rodríguez Roldán, Marta | |
| dc.contributor.author | Garrido Botella, María Isabel | |
| dc.contributor.author | González Cantero, Mercedes | |
| dc.contributor.author | Teja, Macarena | |
| dc.contributor.author | Rosa, Alonso la | |
| dc.contributor.author | Rosel Aller, Rafael | |
| dc.contributor.author | Belinchón Olmeda, Belén | |
| dc.contributor.author | Miralles Olivar, Lara | |
| dc.contributor.author | Duque Santana, Víctor | |
| dc.contributor.author | Et. al. | |
| dc.date.accessioned | 2026-10-05T08:29:18Z | |
| dc.date.available | 2026-10-05T08:29:18Z | |
| dc.date.issued | 2026 | |
| dc.description.abstract | Extracranial oligometastatic disease, defined as up to five metastases, represents an intermediate cancer state with potential for long-term control. Stereotactic body radiotherapy (SBRT) is a non-invasive treatment associated with high local control, limited toxicity, and the ability to delay systemic therapy. This study reports institutional outcomes of SBRT across oligometastatic scenarios. | en |
| dc.description.filiation | UEM | spa |
| dc.description.impact | 2.7 Q3 JCR 2025 | |
| dc.description.impact | 0.833 Q2 SJR 2025 | |
| dc.description.impact | No data IDR 2024 | |
| dc.description.sponsorship | Sin financiación | |
| dc.identifier.citation | Debén Méndez, B., Rodríguez Roldán, M., Garrido Botella, M. I., González Cantero, M., Teja Ubach, M., La Rosa, A., Rosel Aller, R., Belinchón Olmeda, B., Miralles Olivar, L., Enriquez, L. A. G., De Manso De Lema, A., Duque Santana, V., Díez Sebastián, J., & Gonzalez Del Portillo, E. (2026). The role of SBRT as an ablative treatment in oligometastatic patients. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04462-x | |
| dc.identifier.doi | 10.1007/s12094-026-04462-x | |
| dc.identifier.issn | 1699-048X | |
| dc.identifier.issn | 1699-3055 | |
| dc.identifier.uri | https://hdl.handle.net/11268/17459 | |
| dc.language.iso | eng | |
| dc.peerreviewed | Si | |
| dc.relation.publisherversion | https://doi.org/10.1007/s12094-026-04462-x | |
| dc.rights.accessRights | restricted access | |
| dc.subject.other | Medicina | |
| dc.subject.other | Terapia por Láser | |
| dc.subject.other | Radiocirugia | |
| dc.subject.other | Análisis de Supervivencia | |
| dc.subject.sdg | Goal 3: Ensure healthy lives and promote well-being for all at all ages | |
| dc.subject.unesco | Cáncer | |
| dc.subject.unesco | Tratamiento médico | |
| dc.subject.unesco | Investigación médica | |
| dc.title | The role of SBRT as an ablative treatment in oligometastatic patients | en |
| dc.type | journal article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 116a6d00-95bc-49e5-a381-df10a08fde7a | |
| relation.isAuthorOfPublication.latestForDiscovery | 116a6d00-95bc-49e5-a381-df10a08fde7a |
Files
Original bundle
1 - 1 of 1

